Does Dr. KATHERINE CHIKE HARRIS have financial conflicts of interest?

Dr. KATHERINE CHIKE HARRIS (DNP, CPNP, NE) has received a total of $438 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $438 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KATHERINE CHIKE HARRIS?

According to CMS Open Payments data, Dr. KATHERINE CHIKE HARRIS received funding from MEDTRONIC ($197), PIERRE FABRE PHARMACEUTICALS ($122), and GENZYME CORPORATION ($119).

Does Dr. KATHERINE CHIKE HARRIS receive research grants or speaking fees?

Dr. KATHERINE CHIKE HARRIS has received $438 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KATHERINE CHIKE HARRIS

DNP, CPNP, NEReal-Time Hydrated

Specialty: Nurse Practitioner, Pediatrics

Practice Location: CHARLESTON, SC 29425

NPI Number: 1982834693

LIFETIME INDUSTRY VALUE

$438

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. CHIKE HARRIS is a verified Nurse Practitioner, Pediatrics practitioner based in CHARLESTON, SC.

Between 2021 and 2025, Dr. CHIKE HARRIS had an overall industry promotional and research financial footprint of $438 as recorded in the federal CMS Open Payments database.

$438 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. CHIKE HARRIS's primary funding source is MEDTRONIC, which accounts for $197 (representing 45% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MEDTRONIC

Rank 1

$197

45%

PIERRE FABRE PHARMACEUTICALS

Rank 2

$122

27.9%

GENZYME CORPORATION

Rank 3

$119

27.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.